Long-term functional health status and exercise test variables for patients with pulmonary atresia with intact ventricular septum: A Congenital Heart Surgeons Society study  by Karamlou, Tara et al.
C
H
D
CONGENITAL HEART DISEASELong-term functional health status and exercise test variables for
patients with pulmonary atresia with intact ventricular septum:
A Congenital Heart Surgeons Society studyTara Karamlou, MD, MSc,a Jeffrey A. Poynter, MD,b Henry L. Walters III, MD,c Jonathan Rhodes, MD,d
Igor Bondarenko, MD,c Sara K. Pasquali, MD,e Stephanie M. Fuller, MD,f Linda M. Lambert, RN,g
Eugene H. Blackstone, MD,hMarshall L. Jacobs, MD,i KimDuncan, MD,j Christopher A. Caldarone, MD,b
William G. Williams, MD,b and Brian W. McCrindle, MD, MPHkFrom th
sity o
Surge
Ontar
Mich
Mass
eases
Divis
adelp
Hosp
Resea
Cleve
Hosp
pital f
Grant su
Disclosu
Read at
Surge
Receive
for pu
Address
Surge
513
karam
0022-52
Copyrig
http://dx
1018Background: A bias favoring biventricular (BV) repair exists regarding choice of repair pathway for patients
with pulmonary atresia with intact ventricular septum (PAIVS). We sought to determine the implications of
moving borderline candidates down a BV route in terms of late functional health status (FHS) and exercise
capacity (EC).
Methods: Between 1987 and 1997, 448 neonates with PAIVS were enrolled in a multi-institutional study. Late
EC and FHS were assessed following repair (mean 14 years) using standardized exercise testing and 3 validated
FHS instruments. Relationships between FHS, EC, morphology, and 3 end states (ie, BV, univentricular [UV], or
1.5-ventricle repair [1.5V]) were evaluated.
Results:One hundred two of 271 end state survivors participated (63 BV, 25 UV, and 14 1.5V). Participants had
lower FHS scores in domains of physical functioning (P<.001) compared with age- and sex-matched normal
controls, but scored significantly higher in nearly all psychosocial domains. EC was higher in 1.5V-repair pa-
tients (P ¼ .02), whereas discrete FHS measures were higher in BV-repair patients. Peak oxygen consumption
was low across all groups, and was positively correlated with larger initial tricuspid valve z-score (P<.001), with
an enhanced effect within the BV-repair group.
Conclusions: Late patient-perceived physical FHS and measured EC are reduced, regardless of PAIVS repair
pathway, with an important dichotomy whereby patients with PAIVS believe they are doing well despite impor-
tant physical impediments. For those with smaller initial tricuspid valve z-score, achievement of survival with
BV repair may be at a cost of late deficits in exercise capacity, emphasizing that better outcomes may be achieved
for borderline patients with a 1.5V- or UV-repair strategy. (J Thorac Cardiovasc Surg 2013;145:1018-27)e Division of Pediatric Cardiac Surgery,a Benioff Children’s Hospital, Univer-
f California, San Francisco, San Francisco, Calif; Division of Cardiovascular
ry,b The Hospital For Sick Children and the University of Toronto, Toronto,
io, Canada; Department of Cardiovascular Surgery,c Children’s Hospital of
igan, Detroit, Mich; Department of Cardiology,d Children’s Hospital, Boston,
; Division of Cardiology,e Department of Pediatrics and Communicable Dis-
, C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, Mich;
ion of Cardiovascular Surgery,f The Children’s Hospital of Philadelphia, Phil-
hia, Pa; Department of Pediatric Cardiovascular Surgery,g Primary Children’s
ital, Salt Lake City, Utah; Department of Quantitative Health Sciences,h
rch Institute, and Department of Pediatric and Congenital Heart Surgery,i
land Clinic, Cleveland, Ohio; Division of Cardiothoracic Surgery,j Children’s
ital and Medical Center, Omaha, Neb; and Division of Cardiology,k The Hos-
or Sick Children, Toronto, Ontario, Canada.
pport was provided by the Children’s Heart Foundation.
res: Authors have nothing to disclose with regard to commercial support.
the 92nd Annual Meeting of The American Association for Thoracic
ry, San Francisco, California, April 28-May 2, 2012.
d for publication April 24, 2012; revisions received Oct 18, 2012; accepted
blication Nov 6, 2012; available ahead of print Jan 31, 2013.
for reprints: Tara Karamlou, MD, MSc, Division of Pediatric Cardiac
ry, Benioff Children’s Hospital, University of California, San Francisco,
Parnassus Ave, Suite S-549, San Francisco, CA 94506 (E-mail: tara.
lou@ucsfmedctr.org).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.11.092
The Journal of Thoracic and Cardiovascular SurgeSupplemental material is available online.Pulmonary atresia with intact ventricular septum (PAIVS)
has a broad morphologic spectrum hinging in large part
on the degree of hypoplasia of right heart structures. The
Congenital Heart Surgeons Society (CHSS) has previously
shown1,2 that a balanced approach, including selective
application of both biventricular (BV) and univentricular
(UV) repairs based on the initial tricuspid valve z-score
(ITVZ), which is a surrogate measure of right-sided hypo-
plasia, is associated with the highest rates of survival and
achievement of definitive repair. Nonetheless, a bias exists
favoring BV repair in many institutions predicated on the
assumption that BV physiology maximizes long-term func-
tional health status (FHS) and exercise performance. Our
prior investigations1,2 did not consider the influence of
final end state on late FHS outcomes or late exercise
capacity (EC). The question remains, therefore: If one
forces a borderline candidate down a BV-repair pathwayry c April 2013
Abbreviations and Acronyms
1.5V ¼ 1.5 ventricle
BV ¼ biventricular
CHQ ¼ Child Health Questionnaire
CHSS ¼ Congenital Heart Surgeons Society
EC ¼ exercise capacity
FHS ¼ functional health status
ITVZ ¼ initial tricuspid valve z-score
PEDSQL ¼ Pediatric Quality of Life Inventory
RV ¼ Right ventricle
UV ¼ univentricular
VO2 ¼ oxygen consumption
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long-term FHS and quality of life? To address this question,
the CHSS undertook a multicenter cross-sectional study of
surviving patients with PAIVS to determine if BV repair
was associated with a late (10 years) benefit in terms of
FHS and EC relative to UVor 1.5-ventricle (1.5V) repair.C
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Patients
Between 1987 and 1997, 448 neonates with functional PAIVS admitted
to a CHSS institution within 30 days of birth were prospectively enrolled in
a multi-institutional study.1,2 Neonates were managed according to
institutional preference. Median enrollment across the 33 participating
institutions was 12 neonates per institution (range, 1-44 neonates).
Morphologic data were obtained by means of independent review of
preintervention echocardiograms and catheterization results, as
previously described,1,2 with differences between right ventricular (RV)
fistulae and RV sinusoids adjudicated by a senior cardiologist following
review.1,2 For this investigation, we defined those patients who at most
recent follow-up had 2 functional ventricles and in-series pulmonary and
systemic circulations, without systemic-to-arterial shunts or cavopulmo-
nary connection, to have achieved BV repair regardless of the status of
the atrial septum. Patients with antegrade pulmonary blood flow and a cav-
opulmonary shunt formed the 1.5V-repair group. The UV-repair group was
composed of patients who had undergone the Fontan procedure. Although
our initial investigations1,2 considered only what was believed to be true
pulmonary atresia, the rationale for the inclusion criteria of functional
pulmonary atresia in this investigation is provided in Appendix E1. The
CHSS data center maintains annual follow-up of this cohort, with a current
total of 271 (62%) survivors. Annual follow-up included 32% (n ¼ 86) of
the cohort in 2011 and 73% (n¼ 197) within the past 5 years. All surviving
patients from this initial cohort were approached to participate in this cross-
sectional study. All participating centers obtained local institutional review
board or ethics committee approval before initiating the study and written
informed consent or assent was obtained for all subjects.
Exercise Testing
Standardized cardiopulmonary exercise testing was prospectively per-
formed according to the protocols developed by Paridon and col-
leagues.3-5 Summary and graphic data from the metabolic measurements,
electrocardiographic measurements, and pulse oximetry were forwarded
to the data center. In addition, all breath-by-breath metabolic data averaged
over 20-second intervals and electrocardiograms were forwarded to the
CHSS data center. The data were reviewed for quality and measurementsThe Journal of Thoracic and Carmade as described previously in the Pediatric Heart Network Fontan
Cross-Sectional Study.5-9
Functional Status Questionnaires
To assess FHS, the study used 3 standardized survey instruments or
questionnaires: the Child Health Questionnaire (CHQ) child report form,
the teen report and young adult report forms of the Pediatric Quality of
Life Inventory 4.0 (PedsQL), and the Congenital Heart Adolescent and
Teenager Questionnaire. Questionnaires were administered either at the
time of a clinic visit to the CHSS member institution, or by mail with tele-
phone proctor. Ideally, the questionnaires were completed concomitant
with exercise testing, but for subjects for whom this was not possible, ques-
tionnaires were completed and returned by mail within 3 months of exer-
cise testing. The Hollingshead Four Factor Index of Social Status was
administered concurrent with all questionnaires to adjust for the potential
effect of socioeconomic status on FHS.10,11 Details regarding each
instrument are related in Appendix E1.
Statistical Analysis
Data are described as frequencies, medians with ranges, or means with
standard deviations. ITVZ scores were derived using themethod of Rowlatt
and colleagues,12 with informative imputation, when sufficient information
was available, used for missing values. Patients in whom ITVZ score was
missing following imputation (n ¼ 9) were excluded from multivariable
models. Scores (either from questionnaires or exercise tests) were related
to initial morphologic features and other patient variables using multivari-
able generalized linear models, with a separate model for each discrete
score. A comprehensive set of variable transformations were explored to
optimize relationships and model performance. Analysis of each testing
data set (score) was initially performed with all testing variables included
to determine the overall R2 adjusted for the number of included variables.
Stepwise selection was then applied to guide final model selection, with
P< .15 used for inclusion into the final model. Because not all tests
were performed in all patients (Figure 1), analyses were restricted to indi-
vidual test data sets, and no overall analysis incorporating all tests was per-
formed. Particular focus was given to evaluating the relationship of scores
to final end state (BV, UV, and 1.5V), with the end state modeled as an in-
dependent variable. Patients undergoing palliation without definitive repair
and those undergoing heart transplant were not included in the multivari-
able models due to inadequate sample size. Correlations among exercise
testing results and FHS scores were sought using general linear models
and correlational analysis. Because this study involved evaluation of
both subjectivemeasures and objectivemeasures, we performed amultivar-
iate analysis using 4 selected outcome measures (percent predicted of nor-
mal for maximum oxygen consumption [VO2] and maximum heart rate,
Physical Functioning Summary Score from the PedsQL, and Global Gen-
eral Health score from the CHQ) as simultaneous dependent variables to
further explore the simultaneous influence of final end state and evaluate
the amount of variation explained by each discrete measure. Response
bias was sought by comparing categorical data for responders versus non-
responders using c2 or Fisher exact test where appropriate, or by comparing
continuous data for responders versus nonresponders using t tests. Analy-
ses were performed using SAS statistical software version 9.2 (SAS
Institute, Cary, NC).RESULTS
Status of the Cohort: Achievement of End States and
Survival
During the study interval, 448 neonates were enrolled. Of
these, 433 underwent surgery and 15 underwent no cardiac
surgical intervention. Survival status and current end states
of the survivors and the study participants are shown indiovascular Surgery c Volume 145, Number 4 1019
FIGURE 1. Flowchart depicting cross-sectional study participants segre-
gated by current end state. BV, Biventricular repair; UV, univentricular
repair; 1.5V, 1.5-ventricle repair.
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derwent initial palliation have not reached an end state de-
fined in this study, and 33 of these patients remain in
a palliated state (see Figure E1).Study Participation and Patient Characteristics
Of the 271 survivors, 106 (39%) participated in the cross-
sectional study (Figure 1). For participants who have
reached 1 of the 3 end states, the median interval from repair
(ie, an operation that resulted in achievement of an end
state) to completion of the questionnaires was 14.7 years
(range, 3.5-21.8 years), with a median age of 18.6 years
(range, 9.1-23.7 years). A majority of participants had
reached BV repair, with correspondingly fewer patients in
the UVand 1.5V groups. Completion rates for the different
instruments include 77% for exercise testing (n¼ 82), 68%
for CHQ (n¼ 72), 63% for PedsQL (n¼ 67), and 67% for
Congenital Heart Adolescent and Teenager Questionnaire
(n ¼ 71). The Hollingshead Four Factor Score was com-
pleted by 54% (n¼ 57). Initial morphologic characteristics
(including ITVZ, RV size, prevalence of RV fistulae, and
sinusoids) for participants were similar to nonparticipating
survivors from the inception cohort, except that participantsTABLE 1. Participant characteristics (N ¼ 106)
Variable Univentricular B
Age at repair (y) 1.6 (0.6 to 16.6) 1.
Age at evaluation (y) 14.6 (3.7 to 17.9) 14.
Birth weight (kg) 3.3  0.5
Initial TV z-score 3.4 (4.9 to 0.3)y 1.
Initial RVSP (mm Hg) 122  34
RV sinusoids (N [%]) 20 (87%) 1
RV dependent CC (N [%]) 1 (1%)
RV fistulas (N [%]) 14 (56%)
Values are medians with ranges, or mean standard deviation. 1.5V, 1.5-ventricle; TV, tricu
circulation. *Overall P value among end states. yP<.01 compared with reference group (ie
1020 The Journal of Thoracic and Cardiovascular Surhad a lower prevalence of RV-dependent coronary circula-
tion (1 out of 106 [1%] vs 10 out of 165 [6%]; P ¼ .03).
Initial morphologic characteristics for participants segre-
gated by the end state group are shown in Table 1. Not sur-
prisingly, measures consistent with more severe degrees of
right-sided hypoplasia were significantly more prevalent
among the UV-repair group.
Functional Status Results: ComparisonWith Normal
Controls
Important differences existed between published norma-
tive data and the PAIVS cohort as a whole regarding per-
ceived FHS (see Table 2 and Figure E2, A and B). We
noted that patients with PAIVS had lower physical function-
ing scores on both the CHQ and the PedsQL than age- and
sex-matched normal subjects. However, patients with
PAIVS had higher scores than normal subjects on the
CHQ in nearly all psychosocial domains.
Influence of Repair Pathway on FHS Results
The influence of repair pathway on FHS scores is shown
in Table 2 and Figure 2, A. In general, age- and sex-adjusted
scores were lower in UV-repair patients compared with
BV-repair patients, although statistically significant FHS
differences were limited to discrete domains within the
CHQ. Based on the correlation analysis, the CHQ explained
a much greater proportion of the variation than either the
PedsQL or the Congenital Heart Adolescent and Teenager
Questionnaire.
Influence of Repair Pathway on Exercise Testing
Results
Based on standardized late exercise testing among this
cohort, age- and sex-adjusted percent predicted peak VO2
was lowest among UV-repair patients (Table 2). However,
based on our prior results with this cohort2 that related the
importance of a morphologically driven protocol based on
ITVZ in terms of optimizing survival and achievement of
complete repair, we investigated peak VO2 across the spec-
trum of ITVZ scores. Peak VO2 was higher for those
with larger ITVZ for all end state groups (see Figure 3, A)iventricular 1.5V P value*
3 (Birth to 7.0) 1.7 (Birth to 6.7) .07
7 (7.0 to 21.8) 15.5 (4.6 to 17.8) .55
3.5  0.4 3.0  0.4 .11
0 (3.6 to 0.9)y 2.3 (4.1 to 0.3) <.001
110  22z 130  26 .04
1 (19%) 5 (42%) <.001
0 (0%) 0 (0%) .24
4 (6%) 4 (29%) <.001
spid valve; RVSP, right ventricular systolic pressure; RV, right ventricle; CC, coronary
, 1.5V-repair group). zP<.05 compared with reference group (ie, 1.5V-repair group).
gery c April 2013
TABLE 2. Exercise testing and functional health status results for pulmonary atresia with intact ventricular septum (PAIVS) cohort compared
with published normative data followed by results segregated by the 3 specified end states
CHQ
Published normative data Study-specified end states
Normal subjects
(N ¼ 2361)
Overall PAIVS
P value
UV BV 1.5V Overall
P value*N ¼ 70 N ¼ 16 N ¼ 45 N ¼ 9
Global general health NA 80.66  19.89 NA 79.33  19.07 (79.46) 84.26  13.42 (84.24)y 65.55  32.25 (65.13) .05
Physical functioning 94.79  9.59 85.13  16.54 <.001 84.25  13.42 (84.26) 85.61  14.47 (85.62) 84.32  29.33 (84.27) .99
Role social-emotional 88.51  18.54 93.24  16.74 .03 95.83  16.67 (96.00) 93.33  14.68 (93.39) 87.50  26.85 (86.87) .80
Role social-behavioral 92.73  15.94 95.97  11.90 .08 95.14  16.71 (95.32) 96.04  10.64 (96.07) 97.22  7.86 (96.76) .85
Role social-physical 94.58  14.79 93.72  17.82 .64 95.83  16.67 (95.93)z 95.55  11.46 (95.60)z 79.17  37.30 (78.70) .18
Bodily pain 72.8  20.82 88.04  16.82 <.001 87.69  20.48 (88.04) 88.52  14.86 (88.46) 88.67  16.97 (86.17) .98
Behavior 77.51  13.76 81.52  21.85 .03 75.94  30.23 (76.17) 83.18  18.90 (83.11) 83.33  18.54 (83.27) .67
Self-esteem 74.64  17.07 80.84  15.51 .005 76.30  18.57 (76.28) 81.59  15.42 (81.58) 85.22  7.31 (85.29) .71
General health 68.13  15.55 66.38  16.55 .25 63.36  15.51 (63.36) 68.39  14.89 (68.51) 61.71  25.00 (61.14) .51
Family cohesion 71.23  25.99 76.00  23.28 .21 74.38  28.34 (74.73) 76.56  22.53 (76.67) 76.11  19.12 (74.93) .93
PedsQL N ¼ 67 N ¼ 64 N ¼ 14 N ¼ 41 N ¼ 9
Physical Health Summary Score 86.25  10.63 79.85  17.24 .01 77.44  16.65 (77.76) 81.26  17.42 (81.51) 77.14  18.60 (75.53) .46
Psychosocial Health Summary
Score
79.37  15.70 80.90  17.81 .58 78.93  16.79 (79.41) 82.06  18.57 (82.31) 78.70  17.23 (76.77) .28
Exercise testing N ¼ 80 N ¼ 22 N ¼ 45 N ¼ 13
VO2 (% predicted) NA 73.10  15.44 63.96  10.45 (64.02)z 75.78  15.98 (75.76) 77.88  15.37 (77.88) .02
Maximum heart rate (% predicted) NA 82.20  15.61 76.49  10.90 (75.98)z 83.11  17.91 (83.32) 88.40  10.25 (88.49) .18
Values in parentheses represent age- and sex-adjusted regression estimates. CHQ, Child Health Questionnaire; NA, not applicable; PedsQL, Pediatric Quality of Life Inventory
version 4.0. VO2, oxygen consumption; UV, univentricular repair; BV, biventricular repair; 1.5V, 1.5-ventricle repair. *Overall difference among end states. yP<.01 compared
with reference group (ie, 1.5V-repair group). zP<.05 compared with reference group (ie, 1.5V-repair group).
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between peak VO2 and ITVZ within each end state group,
there was a trend whereupon BV repair in patients with
larger ITVZ had improved peak VO2 relative to the UV-
repair group, although there were not enough overlapping
data points to make statistical comparisons between the
UV-repair and the BV-repair groups. Importantly, peak
VO2 in the BV-repair group with low ITVZ scores
(eg,<2), tended to be lower than peak VO2 in the 1.5-
ventricle group with comparable ITVZ scores, (Figure 3, B).
Maximum heart rate was below normal for all groups. Pa-
tients from the 1.5V-repair group were able to reach a signif-
icantly higher heart rate than the UV-repair group (Table 2).
Unlike percent predicted peak VO2, no interaction between
percent predicted maximum heart rate and ITVZ was
observed (Figure E3).
Multivariable factors associated with exercise testing re-
sults and selected FHS domains are listed in Table E1. In ad-
dition to ITVZ, overall end state was also significantly
associated with peak VO2, with the BV-repair group faring
worse than the 1.5V-repair group. The overall R2 for the
peak VO2 model was 0.58, indicating that 58% of the var-
iation in this measure was explained by the variables in-
cluded. Figure E4 is a risk-adjusted nomogram across the
spectrum of participant ages, and demonstrates 3 solutions
for the multivariable peak VO2 equation for a hypothetical
male patient with an ITVZ of 2. Although peak VO2 in-
creased with increasing age in all end state groups, theThe Journal of Thoracic and Car1.5V-repair group had improved peak VO2 compared with
both the UV-repair and BV-repair groups, although this dif-
ference was significant only between the 1.5V-repair and
BV-repair groups. Regarding percent predicted maximum
heart rate, patients with BV repair tended to fareworse com-
pared with the 1.5V-repair group (P ¼ .06), as did patients
with RV fistulae (P¼ .01) and important tricuspid valve in-
competence (P ¼ .05). Socioeconomic status was associ-
ated with most FHS scores, and accounted for the
majority of score variation. We did not find any independent
factors associated with either the physical or psychosocial
summary score evaluated by the PedsQL.
Influence of Repair Pathway on Simultaneous FHS
and EC Measures
The multivariate analysis agreed with our initial analysis,
in that it demonstrated a significant association of FHS with
end state (P ¼ .006 [Wilks’ lambda]). The objective mea-
sures (exercise variables) had the greatest model effect
and accounted for the majority of model variation com-
pared with the subjective measures (FHS scores). The first
eigenroot (corresponding to peak V02) explained 73% of
the variation, and had the largest vector magnitude
(49%), with maximum heart rate being second, explaining
26% of the variation. FHS scores were much less impor-
tant, with vector magnitudes of 0.09 and 0.03 for physical
functioning summary score and global general health,
respectively.diovascular Surgery c Volume 145, Number 4 1021
FIGURE 2. A, Influence of end state on selected functional health status
(FHS) scores. This histogram demonstrates age- and sex-adjusted values
for the 3 end state groups in selected domains. In general, age- and sex-
adjusted FHS measures were similar in patients undergoing univentricular
(UV) repair compared with patients undergoing biventricular (BV) repair.
B, Histogram depicting influence of repair pathway on exercise test results.
Age- and sex-adjusted means for percent predicted peak oxygen consump-
tion (VO2) and maximum heart rate (Max heart rate). The BV group had
lower peak VO2 than the 1.5-ventricle repair (1.5V) group. The 1.5V group
also achieved a higher max heart rate than the UV repair group. *Overall
P value not significant; yOverall P<.05; a ¼ P<.01 compared with the
reference group (ie, 1.5V-repair group); zP<.05 compared with reference
group (ie, 1.5V-repair group).
FIGURE 3. A, Percent predicted late peak oxygen consumption (VO2)
across the spectrum of initial tricuspid valve z-scores for all participants.
Peak VO2 increased linearly with increasing initial tricuspid valve z-score
for all participants (P<.001). Solid line is a best-fit regression lines en-
closed by 95% confidence limits. Individual dots represent individual
data points. B, Percent predicted late peak VO2 among the 3 end state
groups over the range of initial tricuspid valve z-scores with risk-
adjusted best-fit regression lines for each group. Peak VO2 was higher
for those with larger initial tricuspid valve z-score for all end state groups
(P< .001). It appears that biventricular (BV) repair in patients with the
highest values of initial tricuspid valve z-score (>0) was associated with
higher peak VO2 than was observed in other treatment groups. This is
based on a very small number of patients in the BV group with initial tri-
cuspid valve z-score values higher than all patients in the other treatment
groups. Importantly, peak VO2 in the BV group with low initial tricuspid
valve z-scores (eg,<2) tended to be lower than peak VO2 in the 1.5–ven-
tricle-repair group with comparable initial tricuspid valve z-scores.
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Exercise Testing Results Following Repair of PAIVS:
The Importance of Initial Tricuspid Valve z-Score
Wehave shown that latemeasures of aerobic capacity (eg,
peak VO2) and chronotropic competence (eg, maximum
heart rate) are lower in late survivors with PAIVS than in
normal control subjects, regardless of the type of PAIVS re-
pair achieved. Although our previous study concluded that
ITVZ is an important determinant of survival and end state
achievement,2 these results provide further support for clin-
ical use of ITVZ (a discrete morphologic measure that is1022 The Journal of Thoracic and Cardiovascular Surreadily available at initial presentation) in surgical decision
making by exposing a relation to late peak VO2. In addition
to increased risk of death, patients with more severe degrees
of initial right heart hypoplasia who are forced down a BV
pathway also incur greater risk of late deficits in aerobic ca-
pacity. Although we were not able to determine an absolute
threshold at which a UV repair is preferable to a BV repair,
our results are provocative and question the current wisdomgery c April 2013
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mance. Sanghavi and colleagues13 compared exercise test
results of patients with PAIVS repaired by either BV-
(n ¼ 19) or UV- repair strategies (n ¼ 10). Similar to our
findings, they observed that patients who had undergone
UVor BV repairs had subnormal aerobic capacity and over-
all peak VO2 did not vary between these repair types. How-
ever, chronotropic function was significantly better in the
latter group, whereas we observed a trend favoring better
chronotropic response in patients undergoing 1.5V-repair.
In another recent report by Romeih and colleagues,14 16 pa-
tients (7 UV, 7 BV, and 2 1.5V) underwent comprehensive
exercise testing and myocardial perfusion studies. The
UV-repair group had significantly reduced exercise capacity,
whereas the BV-repair group had normal exercise test re-
sults. With dobutamine stress imaging, left ventricular
stroke volume increased only in the BV-repair group, and
the UV-repair group exhibited significant chronotropic in-
sufficiency. Results for their 1.5V-repair group were similar
to those of their UV-repair group. These results are concor-
dantwith our univariable analysis, but are discordant follow-
ing risk adjustment for other important variables such as the
ITVZ,whereby the BV-repair group performed significantly
worse.
Patients who had achieved 1.5V repair had higher peak
VO2 values over the same range of ITVZ compared with
patients undergoing BV repair, and also tended to achieve
higher maximum heart rates. This has an important physio-
logic correlate in that, for some patients with smaller initial
ITVZ, it is plausible that the addition of a cavopulmonary
connection to antegrade flow through the RV outflow tract
might supplement cardiac output, thereby increasing late
exercise test results. One might also speculate that patients
with 1.5V repairs may incur less injury to the sinoatrial
node due to lower risk of pressure elevation and surgical
trauma. One caveat, however, is that small improvements
in aerobic capacity and chronotropic response within the
1.5V-repair group were not accompanied by enhanced
self-perceived FHS. Unfortunately, there are no studies
that have examined both exercise testing and FHS concur-
rently within patients undergoing 1.5V repair. Numata
and colleagues15 performed exercise testing in 3 of 13 pa-
tients who underwent 1.5V repairs for functional PAIVS.
They concluded that in that small group, exercise test results
were equivalent to a group of 26 Fontan patients with tricus-
pid atresia. The small numbers from this study and the lack
of a true anatomic comparison group undergoing both UV
and BV repair make inferences relative to our study diffi-
cult. Certainly, further studies directed at late outcomes in
the 1.5V-repair group are needed given the findings from
our current investigation.
Interestingly, our study demonstrated that ITVZ score
was positively correlated with peak VO2 even in the
UV-repair group. Influence of a structure in the nonsystemicThe Journal of Thoracic and Carventricle was also demonstrated in the CHSS critical left
ventricular outflow tract obstruction cohort study, where-
upon small mitral valve z-score was predictive of death in
UV-repair patients, but not in BV-repair patients.16 The as-
sociation of greater right-sided hypoplasia with a higher
prevalence of RV-dependent coronary circulation is 1 possi-
ble explanation for our findings. Although it is true that we
did not find a high prevalence of RV-dependent coronary
circulation in this cohort, the number of patients was per-
haps insufficient along the spectrum of severe tricuspid
valve hypoplasia to exclude this as a possibility. For exam-
ple, in the participating cohort, the median ITVZ score was
1.8; in the initial cohort it was 2.2. Similarly, in the par-
ticipating cohort there was only 1% prevalence of
RV-dependent coronary circulation compared with 8% in
the initial cohort. It has also been suggested by Tanoue
and colleagues17 that a small, hypertensive RV may impair
left ventricular performance after UV repair. Another po-
tential explanation is that small ITVZ score is correlated
with other harmful effects, including an increased number
of interventions or operations, remaining in a palliated state
with volume overload or cyanosis, or younger age at sur-
gery, which could influence late exercise capacity in a man-
ner we have not currently measured. Finally, ventricular
interdependence in the context of very large RV volumes
may impede left ventricular function, but it is plausible
that a more modest degree of RV enlargement may not
have the same detrimental effects vis-a-vis septal shift.
FHS Outcomes Following Repair of PAIVS
We found that patients with PAIVS scored lower than
age- and sex-matched normal controls, but they performed
better in nearly all psychosocial and relationship domains.
Such evidence is important because it demonstrates, espe-
cially when coupled with EC data, that patients with PAIVS
patients believe they are doing well despite their important
physical impediments. In other words, there is a discrepancy
between the subjective self-perception and the objective
metrics of performance among our cohort of repaired survi-
vors with PAIVS.
Significance of This Study
The multifactorial determinants of definitive end states in
neonates with PAIVS, including mortality (pre- and postre-
pair) and achievement of complete repair, have been previ-
ously described.1,2,18-22 However, improved survival
beyond complete repair in the contemporary era (to nearly
98% at age 7 years in 1 study22) has refocused attention
on other important outcome measures, such as FHS and
long-term quality of life. Assessment of these outcomes
are particularly important for patients with PAIVS for sev-
eral reasons: (1) the wide morphologic spectrum enables
a range of repair options, (2) a significant degree of morpho-
logic overlap or gray zone exists in which evidence-baseddiovascular Surgery c Volume 145, Number 4 1023
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ing BV repair in the absence of clear supporting evidence.
Although prior reports have described FHS outcomes
among patients with congenital heart disease,4,8,23-28 these
studies have relied on comparisons to healthy subjects.
Our study is unique in that it provides 3 diagnosis-
concordant and concurrently obtained comparison groups
(BV-, UV-, and 1.5V-repair groups), rather than relying
solely on healthy children as controls.
Relationship Between Performance Scores
We found modest positive correlation between exercise
testing measures and FHS scores (Appendix E2), although
stronger than those associations reported in recent publica-
tions.6,8,24 The CHQ had the best correlation among the 3
questionnaires studied, suggesting that this may be the
optimum instrument to evaluate FHS within PAIVS, given
the implicit limitation of comparing an objective
measurement to a subjective or self-perceived measure-
ment. Improved instrument performance may be due to
the comprehensive nature of the CHQ (87 questions) rela-
tive to the PedsQL (23 questions), or the CHAT (45 ques-
tions), or to enhanced discrimination within domains
related to physical functioning.
Noncardiac Factors Associated With Performance
Measures
Although the major focus of our investigation was to de-
termine the relationship of initial morphologic factors and
end states on late FHS, we anticipated based on previous
data5,8,23-35 and an unpublished report by Kulik and
colleagues that noncardiac factors might contribute to
these outcomes. McCrindle and colleagues5,8 found in
a cross-sectional evaluation of Fontan patients that noncar-
diac medical conditions and psychosocial factors were
likely to be more important factors associated with FHS
than objective measurements of cardiopulmonary function.
Similarly, Culbert and colleagues24 reported that the per-
cent variation in CHQ scores explained by cardiac factors
was small (R2, 0.02-0.26) among 306 patients following re-
pair of transposition of the great arteries. In our study, we
determined that socioeconomic status was associated with
both exercise testing measures and FHS scores, and ex-
plained a considerable amount of the variation in scores.
These results highlight the importance of comprehensive re-
habilitation programs designed to address not only a pa-
tient’s cardiac conditions and its sequelae, but his/her
psychosocial environment and perceptions.
Limitations
Although functional assessment was performed prospec-
tively, we cannot exclude selection or ascertainment bias as
a confounder given that not all eligible survivors partici-
pated in the cross-sectional evaluation. That responders1024 The Journal of Thoracic and Cardiovascular Surwere generally similar to nonresponders, however, limits
this source of bias. Missing data in potentially important
variables, including the status of the atrial septum and
whether or not peak effort was achieved on exercise testing,
may have influenced our findings. The current focus on
effort-independent submaximal indices may offer more
useful information in children and adolescents than peak
VO2. Not all patients completed both exercise testing and
FHS tests, which limited the available data as well. Further-
more, the lack of concomitant echocardiography or supple-
mental medical information precludes the integration of our
measured outcomes with individual clinical context. We ac-
knowledge the subjectivity inherent to all functional health
status instruments, although the use of 3 separate and
widely validated questionnaires somewhat mitigates this
limitation. Finally, the comparison to normal subjects’
data (although a minor component of this study) must be
tempered by the knowledge that subtle differences may ex-
ist between the normative data utilized and our population.
The z-scores calculated in our study were derived from the
pathologic study of Rowlatt and colleagues,12 which uti-
lized formalin-fixed heart specimens. Given that all cardiac
structures are known to shrink during the fixation process,
these z-scores will result in larger numbers than z-scores
calculated based on echocardiographic normative data.36
We chose to use Rowlatt’s data, recognizing these limita-
tions, to maintain consistency with prior CHSS publications
involving this cohort.1,2CONCLUSIONS
Late patient-perceived physical FHS and measured EC
are reduced, regardless of PAIVS repair pathway, with an
important dichotomy whereby PAIVS patients believe
(based on improved psychosocial FHS scores relative to
normal controls) they are doing well despite significant
physical impediments. For selected patients with borderline
degrees of right-sided hypoplasia (ie, those patients who do
not meet clear criteria for either BVor UV repair), selection
of a BV repair may result in reduced late EC. The addition
of a cavopulmonary connection may represent a viable sur-
gical option in this setting given its association with im-
proved late aerobic and chronotropic function.
Conversely, patients with more severe initial right-sided hy-
poplasia managed with BV repairs will likely have reduced
late aerobic capacity. These findings underscore the need
for a balanced approach to repair of PAIVS. In addition,
our study emphasizes the clinical utility of ITVZ as an im-
portant determinant not only of survival and achievement of
definitive repair, but also of late aerobic capacity and FHS.References
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Dr V. Mohan Reddy (Stanford, Calif). This study primarily
sought to evaluate the effect of a strategy of repair on late func-
tional outcomes and exercise capacity, especially to see if the
biventricular strategy was superior to the single-ventricle or
1.5-ventricle repair strategy. Despite the limitation that only
39% of the survivors participated in the study and only 63% to
77% completed all the tests, the study provides important infer-
ences and is definitely a major contribution to the field.
The major strength in these 3 groups—namely, the biventricu-
lar, 1.5-ventricle, and single-ventricle groups—is that they are di-
agnosis–concordant and that the initial strategy of surgical repair is
based on sound principles. It also appears that forcing biventricular
repair in patients with lower z-scores reflects our obsession with
2-ventricle repairs, and perhaps this data will compel us to rethink
that strategy. Having said that, I have several questions. First, were
there enough patients in each group who completed all the tests? If
so, did you analyze them separately?
Dr Karamlou. That’s a very important question, as was the ini-
tial question, which was to determine if there is a tricuspid valve
cutpoint that can guide all of our clinical decision making. Unfor-
tunately, we were not able to determine a definitive cutpoint based
on this study. I can tell you that if you look at the data and youdiovascular Surgery c Volume 145, Number 4 1025
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-2 would give you a statistically significant difference between
a univentricular repair on one hand and a biventricular repair on
the other hand. But unfortunately, when you look at this as
a continuum, we couldn’t determine the threshold that you’re
seeking.
Dr Reddy. Thank you. The second question is: Within the bi-
ventricular group is there a cutoff of initial tricuspid valve z-score
that predicted the functional capacity and the exercise capacity?
Dr Karamlou. That’s an important question that we sought to
answer and determine if there is a cutpoint that can guide all of
our clinical decision making. Unfortunately, we were not able to
determine a definitive cutpoint based on this study. I can tell you
that if you look at the data and you segregate things, it looks
like a tricuspid valve Z-score of about minus 2 would give you
a statistically significant difference between a univentricular repair
on one hand and a biventricular repair on the other hand. But un-
fortunately, when you look at this as a continuum, we couldn’t de-
termine the threshold that you’re seeking.
Dr Reddy. Within the biventricular group did you see if pres-
ence or absence of atrial septal defect influenced functional and ex-
ercise capacity?
Dr Karamlou. Yes. Unfortunately, in this particular study we
did not have echocardiographic information that was concomitant
with all of the functional health status testing. That’s something we
hope to achieve in the future. So we didn’t with absolute certainty
know the status of the atrial septum. Now, if we knew it to be
closed based on the yearly follow-up that the data center maintains
on this cohort, we included that. But we cannot be certain that we
know the status of the atrial septum contemporaneous with our
evaluation.
Dr Reddy. That may be an important factor to see if having an
atrial septal defect would increase enough cardiac output vis-a-vis
the cavopulmonary shunt in 1.5-ventricle repair patients.
Dr Karamlou. Yes, absolutely, I agree.
DrReddy. The next question to you is: How do you explain that
the initial tricuspid valve size also correlated with peak oxygen up-
take (VO2) even in patients with a single ventricle?
DrKaramlou.Wewere perplexed initially by that relationship.
But having looked at this retrospectively as well among our other
cohorts, we saw essentially the same finding in the patients with
critical aortic stenosis and aortic valve atresia, whereby the status
of the mitral valve was influential in outcome even within patients
who were triaged to a single-ventricle repair. So exactly the con-
verse on the other side was true in that cohort.
Additionally, there are a couple of other things that one can
speculate. One is that among other types of diagnoses there is ven-
tricular interdependence and there is a ventricular interaction, so it
could be that patients along the spectrum in the univentricular
group with larger right ventricles—and therefore a large right ven-
tricular mass—have some interaction with the systemic cardiac
output, and that may influence their aerobic capacity. Second, per-
haps the tricuspid valve z-score is surrogating other unfavorable or
favorable anatomic characteristics like pulmonary arborization
that unfortunately we could not look at.
Dr Reddy. I encourage you to add a paragraph to that effect in
your discussion.
Dr Karamlou. Yes, that’s a good point.1026 The Journal of Thoracic and Cardiovascular SurDr Reddy. The next question: Peak VO2 was higher in 1.5-ven-
tricle repair compared with biventricular repair regardless of the
z-score, which suggests that tricuspid valve is not the only factor
but right ventricle end-diastolic pressures or tricuspid insuffi-
ciency may be important and a cavopulmonary shunt might offset
these factors. So my question based on this is: Should we consider
the 1.5-ventricle option for patients with pulmonary atresia with
intact ventricular septum, for all patients pulmonary atresia with
intact ventricular septum, regardless of the initial tricuspid valve
size?
Dr Karamlou.Yes, I think that question is anticipated based on
these data, and I don’t think what we’re trying to convey is that for
every anatomic subtype you should always do a 1.5-ventricle re-
pair. Again, we have to be circumspect. This was a small group
of patients—only 14 in the 1.5–ventricle-repair group—and al-
though statistically significant, the range of tricuspid valve
z-scores on either side of those lines is small. There is a physiologic
correlate to our findings in that patients with a 1.5-ventricle strat-
egy may be able to augment their cardiac output and therefore im-
prove their aerobic capacity. But again, it’s a small group of
patients and warrants further study.
Dr Reddy. Do you plan to investigate any neurodevelopment-
related outcomes in these 1.5-ventricle group patients that might
suggest that to increase the pressure in the superior vena cava
may have some implications in developmental outcomes? That
might offset recommending 1.5-ventricle repairs as opposed to
just relying on peak VO2.
Dr Karamlou. I only presented the peak VO2 data in the inter-
est of time. There are obviously comprehensive exercise variables
that we plan to look at in a separate manuscript.
In terms of the neurodevelopment-related outcomes, although
we could look at these data cross-sectionally, all would be con-
founded by not knowing what the patients started with initially.
We know from data from Children’s Hospital of Philadelphia
that these patients start out with very different neurologic pheno-
types that probably influence outcome. So although we could
look at it late, I’m not sure we could make a strong conclusion.
Dr Reddy. It might simply show if there is any effect of
increased superior vena cava pressure.
Dr Karamlou. That’s true.
Dr Reddy.My last question is: We all know that tricuspid valve
size changes as patients grow, depending upon various factors—
whether or not there is the presence of ASD, because that might
influence the amount of blood going across the tricuspid valve;
what the right ventricle end-diastolic pressure is; and what the
right ventricular function is. So if the tricuspid valve size is defi-
nitely influenced by growth, did you make any attempt to compare
the exercise capacity outcomes vis-a-vis the current tricuspid valve
z-score rather than the initial tricuspid valve z-score?
Dr Karamlou. Unfortunately we don’t have the echocardio-
graphic data contemporaneous with the exercise testing. So the
thought of the current investigation was to correlate late functional
health status with initial morphology. We don’t really know what
the tricuspid valve z-score in all patients is contemporaneous with
the functional status or the exercise testing.
Dr Reddy. I think it’s very relevant because it’s important to
know what the current size of the tricuspid valve is. And how it
has grown compared to the original size.gery c April 2013
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patients on a Fontan pathway may actually have a different trajec-
tory than biventricular repair patients. Their course isn’t static, and
so getting the echo and other ancillary data about how the patients
are doing clinically at the time of their functional status evaluation
would give us additional context in which to interpret these results.
Dr John Foker (Minneapolis, Minn). It’s important to have all
the variables when you design a study. The main issues in these pa-
tients are right ventricular and tricuspid hypoplasia. So the impor-
tant question and variable is the possibility of growth. It does not
seem logical to decide to do a single or a biventricular repair if
catch-up growth will erase the hypoplasia.
My question was going to be about growth; however, you have
already discussed that you did not analyze how well the biventric-
ular repairs grew or the difference in tricuspid valve scores with
time. My group’s previous research found that even a -4 tricuspid
valvewill grow up to normal size if you achieve total relief of right
ventricular outflow obstruction, a restrictive atrial septal defect to
encourage tricuspid valve flow yet maintain an adequate cardiac
output, and ligation of all the important coronary artery fistulas
or connections. My recommendation would be to have a growth
arm in these studies in the future.
My final point is that some children with biventricular repairs
will start to miss their pulmonary valve at about age 15 years.
They may have reduced exercise capacity until somebody screws
in a pulmonary valve. With a pulmonary valve in place these pa-
tient should have improved exercise capacity.
Dr Karamlou. Growth observation was actually in our initial
grant application and for pragmatic purposes we chose to presentThe Journal of Thoracic and Car
H
Dthe data we have. Certainly serial echocardiographic data are a crit-
ical component when studying this patient population.
Dr Charles Fraser (Houston, Tex). Would you speculate a little
bit more about the subjective findings in these patients? To me
that’s the most encouraging thing that you presented. Although
we want to make decisions using objective scientific data, if pa-
tients perceive themselves as doing well that’s a very good thing.
And it’s fascinating.
I’ll share a quick anecdote if I might. I just interviewed last
week a 77-year-old woman who was operated on by Dr Blalock
at age 5 years. She lived with a Blalock shunt for 50 years. She’s
had a wonderful life. She says ‘‘I love doctors.’’ Her quality of
life, from her perspective, was outstanding; from ours, she looked
very disabled. What do you think about that and what can we learn
from that going forward?
Dr Karamlou. It is very encouraging and important that there
is a discrepancy between the subjective and the objective mea-
sures. Such a dichotomy has been seen in other studies; patients
with congenital heart disease often believe they’re doing better
than control subjects. And it may be that there are multiple envi-
ronmental factors. For example, it may be that people pay more
attention to these patients as children. Psychosocial and emo-
tional functioning is something we don’t really understand and
it’s probably much more complex than putting somebody on
a treadmill. Or, it may be that domains like bodily pain are cali-
brated differently. If you’ve experienced multiple operations,
well, your idea of severe pain is probably different than some-
body who has not undergone surgical procedures. It is fodder
for additional studies.diovascular Surgery c Volume 145, Number 4 1027
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APPENDIX E1. METHODS
Inclusion Criteria
A prior report from the Congenital Heart Surgeon’s Society2 reported
outcomes of 408 of these patients with pulmonary atresia with intact ven-
tricular septum, whereupon atresia was defined as the absence of any ante-
grade flow through the native right ventricular outflow tract based on all
available data. However, concurrent with this cohort were 40 additional pa-
tients with critical pulmonary stenosis followed annually by the data center.
Consensus among the authors was to include these patients in the analysis
for 2 reasons: comprehensive chart review of these patients revealed that 9
actually had atresia based on the aforementioned criteria, and the remain-
ing 31 had discrepant findings regarding the status of the right ventricular
outflow tract (ie, surgery revealed an imperforate valve, whereas cardiac
catheterization or echocardiography demonstrated a trace of antegrade
flow) and several of the critical pulmonary stenosis patients had clinical
courses reminiscent of patients with pulmonary atresia with intact ventric-
ular septum with severe right ventricular hypoplasia and right ventricular
dependent coronary circulation in that they developed myocardial ischemia
and hemodynamic instability with right ventricular decompression.
Functional Health Status Instruments
The Child Health Questionnaire (CHQ) was utilized in this study. The
CHQ is a generic, but pediatric-specific, assessment tool to assess physical
and psychosocial functional status of children between ages 5 and 18
years.26,27 The child report form is composed of 87 items and has been
validated for children aged 10 to 18 years.5,8,15 Domain scores are
provided for the child report form (ie, summary scores are not available)
to reflect physical functional status and psychosocial status (eg,
emotional, behavioral, and social). Multiple prior publications from our
group and others have utilized this instrument to assess functional status
in patients following congenital heart surgery.5,8,15 The CHQ measures
11 child health concepts, with each being scored on a scale of 0 to 100.
Higher scores indicate better self-perceived function. Child report CHQ
scores were converted to z-scores on the basis of published normative
data.28
The Pediatric Quality of Life Inventory (PedsQL) is a multi-item ques-
tionnaire assessing perceived functional health status (FHS) in children and
adolescents aged 2 to 25 years.29-31 The 23-item PedsQL 4.0 Generic Core
Scales assess physical (8 items), emotional (5 items), social (5 items), and
school functioning (5 items). Separate self-report and parent–proxy forms
exist for ages 5 to 7 years, 8 to 12 years, and 13 to 18 years. A young adult
self-report form is available for patients aged 18 to 25 years. This study uti-
lized the teen report form for patients aged 13 to 18 years, and the young
adult form for patients aged 18 to 25 years. All items use a 5-point Likert
scale designed to assess quality of life and level of functioning. Respon-
dents report how often they experience specific problems grouped by func-
tional domain (0 ¼ never a problem, 1 ¼ almost never, 2 ¼ sometimes,
3 ¼ often, and 4 ¼ almost always a problem). Items are reverse-scored
and linearly transformed to a scale from 0 to 100, with 100 representing
no problems within a functional domain and therefore the highest possible
score. The emotional, social, and school functioning scores can be com-
bined and averaged to generate a psychosocial health summary score.
PedsQL scores were converted to z-scores on the basis of published norma-
tive data.31
The Congenital Heart Adolescent and Teenager Questionnaire (CHAT)
represents a congenital heart disease-specific FHS instrument designed for
pediatric patients with congenital heart disease between ages 10 and 18
years.32-34 The preliminary version of the CHAT was developed by
Kendall and colleagues23 after interviewing 37 adolescents with congenital
heart disease regarding health-related concerns and self-perceived func-
tional status. The questionnaire was then modified and piloted by Kulik
and colleagues (unpublished data, 2006) within an outpatient cardiology
clinic. Domains include the effects of congenital heart disease on general
health, perceived seriousness of heart condition, symptoms/discomforts,
activity limitations, effects on social life, emotional problems, friendship
problems, and effect on career/education. Lower scores in CHAT domains
represent higher FHS. The CHATwas used in this study because it provides
an assessment of FHS that is disease- and age-specific for patients with
congenital heart disease.
APPENDIX E2. RESULTS
Correlation Between Exercise Test Measures And
Functional Status Questionnaires
The percent variation in peak oxygen consumption
(VO2) accounted for by Child Health Questionnaire
(CHQ) domain scores was 56% (R2, 0.56), with higher
peak VO2 significantly related to higher physical function-
ing z-score (parameter estimate 0.06  0.03; P ¼ .058).
Similarly, the percent variation in maximum heart rate ex-
plained by the cumulative CHQ domain scores was 47%
(R2, 0.47), with higher maximum heart rate associated
with higher physical functioning z-score (parameter esti-
mate 0.05  0.03; P ¼ .07). The percent variation in both
peak VO2 and maximum heart rate explained by the Pedi-
atric Quality of Life Inventory (PedsQL) summary scores
(4% and 13%, respectively) and the Congenital Heart
Adolescent and Teenager Questionnaire (CHAT) (17%
and 18%, respectively) was much lower, with no significant
associations detected. Peak VO2 scores were weakly corre-
lated with physical functioning (R, 0.35; P ¼ .02) and
global health domains (R, 0.29; P ¼ .06) in the CHQ, and
with the friends (R, 0.32; P ¼ .04) and emotions domains
in the CHAT (R, 0.33; P ¼ .04). Maximum heart rate
scores were weakly correlated with global health (R, 0.37;
P ¼ .01), physical functioning (R, 0.42; P ¼ .004), bodily
pain (R, 0.36; P ¼ .048), and general health perceptions
(R, 0.39; P¼ .008) in the CHQ. Maximum heart rate scores
were also weakly correlated with the physical functioning
domain in the PedsQL (R, 0.37; P¼ .01) and with the activ-
ity (R, 0.33; P ¼ .03) and discomfort domains (R, 0.22;
P ¼ .05) in the CHAT. Importantly, patients in the
1.5-ventricle repair group achieved greater maximum
heart rates than the biventricle repair group, yet had re-
ported lower measures of functional health status
(Figure 2, A and B).
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FIGURE E1. Flowchart depicting the final end states and survival among
the entire cohort of patients with pulmonary atresia with intact ventricular
septum (PAIVS). BV, Biventricular repair; UV, univentricular repair;
1.5V, 1.5-ventricle repair.
FIGURE E2. A, Histograms demonstrating functional health status re-
sults obtained from the Child Health Questionnaire (CHQ) for all partici-
pants with pulmonary atresia with intact ventricular septum (PAIVS)
compared with age- and sex-matched normal controls. Participants scored
lower than age- and sex-matched normal controls in physical functioning,
but they performed better in psychosocial and relationship domains. Such
evidence is important because it demonstrates that patients with PAIVS
believe they are doing well despite their important physical impediments.
B, Histograms demonstrating functional health status results obtained from
the Pediatric Quality of Life Inventory 4.0 (PedsQL) for patients with
PAIVS compared with age- and sex-matched normal controls. Concordant
with the CHQ, participants with PAIVS scored lower in domains of phys-
ical functioning compared with normal control subjects, but were equiva-
lent in psychosocial domains. PF, Physical functioning; RS-E, role
social-emotional; RS-B, role social behavioral; BP, bodily pain; BE, behav-
ioral; SE, self-esteem; GH, general health; FC, family cohesion. *P  .05.
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FIGURE E3. Percent predicted late maximum heart rate among the 3 end
state groups over the range of initial tricuspid valve z-scores with risk-
adjusted best-fit regression lines for each group. Although the 1.5-
ventricle (1.5V) repair group achieved higher maximum heart rate than
the biventricular (BV) repair group, there was no influence of initial tricus-
pid valve z-score. UV, Univentricular.
FIGURE E4. Risk-adjusted nomogram of peak oxygen consumption
(VO2) across the range of participant ages demonstrates 3 solutions for
the multivariable peak VO2 equation for a hypothetical male patient with
an initial tricuspid valve z-score of 2. Although peak VO2 increases
with increasing age in all end state groups, the 1.5-ventricle repair group
had improved peak VO2 compared with both the biventricular-repair and
univentricular-repair groups, although this difference was significant only
between the 1.5–ventricle-repair group and biventricular-repair group.
TABLE E1. Independent factors associated with exercise test
variables and selected functional health status domains
Variable
VO2
Estimate ± SE P value
Age at evaluation (y) 0.002  0.02 .80
Boys 0.04  0.04 .35
Univentricular end state 0.02  0.07 .11
Biventricular end state 0.18  0.07 .02
1.5 Ventricle end state Reference group
Tricuspid valve z-score 0.11  0.02 <.001
Age and sex included in all models as normalizing variables; other candidate variables
tested but not found to be significant include number of procedures, interval from repair
to evaluation, presence of atrial septal defect, right ventricular systolic pressure, and
Hollingshead score. Model R2, 0.59. VO2, Oxygen consumption; SE, standard error.
Variable
Maximum heart rate
Estimate ± SE P value
Age at evaluation (y) 0.01  0.01 .16
Girls 0.001  0.07 .98
Univentricular end state 0.05  0.11 .64
Biventricular end state 0.19  0.09 .06
1.5 Ventricle end state Reference group
Tricuspid valve incompetence 0.25  0.12 .05
Coronary-cameral fistulae 0.30  0.11 .01
Hollingshead score 0.007  0.003 .05
Age and sex included in all models as normalizing variables; other candidate vari-
ables tested but not found to be significant include number of procedures, interval
from repair to evaluation, presence of atrial septal defect, right ventricular systolic
pressure, and tricuspid valve z-score. Model R2, 0.47. SE, Standard error.
Variable
CHQ global health score
Estimate ± SE P value
Age at evaluation (y) 0.002  0.06 .98
Girls 0.40  0.30 .19
Univentricular end state 0.46  0.56 .42
Biventricular end state 0.28  0.49 .58
1.5 Ventricle end state Reference group
>5 procedures 0.67  0.52 .20
Coronary-cameral fistulae 0.68  0.47 .15
Hollingshead score 0.03  0.02 .07
Age and sex included in all models as normalizing variables; other candidate vari-
ables tested but not found to be significant include tricuspid valve incompetence,
interval from repair to evaluation, presence of atrial septal defect, right ventricular
systolic pressure, and tricuspid valve z-score. Model R2, 0.26. CHQ, Child Health
Questionnaire; SE, standard error.
Variable
CHQ role social physical functioning score
Estimate ± SE P value
Age at evaluation (y) 0.009  0.03 .77
Girls 0.03  0.19 .86
Univentricular end state 0.47  0.33 .15
Biventricular end state 0.79  0.29 .009
1.5 Ventricle end state Reference group
Tricuspid valve z-score 0.16  0.10 .09
Age at repair (y) 0.07  0.04 .11
Hollingshead score 0.02  0.01 .12
Age and sex included in all models as normalizing variables; other candidate vari-
ables tested but not found to be significant include interval from repair to evaluation,
presence of atrial septal defect, right ventricular systolic pressure, and right ventric-
ular fistulae. Model R2, 0.13. CHQ, Child Health Questionnaire; SE, standard error.
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